BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein

Since first reported in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly acquiring mutations, particularly in the spike protein, that can modulate pathogenicity, transmission and antibody evasion leading to successive waves of COVID19 infections despite an unprecedented...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mohanraj Manangeeswaran, Derek D. C. Ireland, Seth G. Thacker, Ha-Na Lee, Logan Kelley-Baker, Aaron P. Lewkowicz, Paul W. Rothlauf, Marjorie Cornejo Pontelli, Louis-Marie Bloyet, Michael A. Eckhaus, Mirian I. Mendoza, Sean Whelan, Daniela Verthelyi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-07-01
Colecção:	Frontiers in Immunology
Assuntos:	SARS-CoV-2 spike protein neurotropism BSL-2 mouse model pseudotyped virus ACE2 transgenic mice
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.919815/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!